Trials / Terminated
TerminatedNCT04891185
Visualisation of Indocyanine Green in Primary and Interval Debulking for Ovarian Cancer
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Visualise peritoneal lesions of epithelial ovarian cancer (EOC) in both primary and interval debulking surgery by using intravascular indocyanine green (ICG) and near-infrared (NIR) light. This Trial wants to investigate whether ICG can increase the visibility of peritoneal lesions and can differentiate between peritoneal implants and fibrosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indocyanine green | Administration of the IMP: Indocyanine green, 0,25mg/kg of body weight, intravenous bolus injection |
Timeline
- Start date
- 2021-10-01
- Primary completion
- 2023-10-01
- Completion
- 2023-10-01
- First posted
- 2021-05-18
- Last updated
- 2023-10-05
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04891185. Inclusion in this directory is not an endorsement.